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Abstract: The analysis of genomic DNA is widely-used for research, forensic and diagnostic purposes. Here we describe 
reliable methods for isolation of cell-free DNA and cellular DNA from urine. Both DNA fractions are suitable for PCR 
and Methylation-Specific PCR (MSP) amplification, leading to consistent and reproducible results. A kinetics analysis de-
scribes the decline of efficiency of MSP performed with urinary DNA which had been stored at room temperature with 
and without proteinase K for various time periods.  
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 For research purposes, DNA is frequently required in 
order to determine genetic variability in defined populations 
and to identify genomic and epigenomic alterations in dis-
ease. In forensic science, DNA analyses aid enquiries associ-
ated with criminal offenses and missing persons investiga-
tions, often based on trace amounts of genetic material [1]. 
Forensic scientists frequently utilize repetitive DNA ele-
ments for gender and species identification or inference of 
human ancestry [2]. An emerging application of DNA-based 
assays is disease diagnostics, including the diagnosis of 
bladder and prostate cancers, the main urological causes of 
morbidity and mortality worldwide [3,4]. Novel potent bio-
markers may detect these malignancies earlier and with 
greater accuracy and may even help to discriminate between 
various tumor subclasses, a step further towards individual-
ized medicine. Thus, they could contribute as well to im-
prove the therapeutic success.  
 Urinary DNA derives from either cell-free DNA originat-
ing from apoptotic or-, necrotic urothelial, tumor or blood-
derived cells [5,6] or from intact cells shed into urine, such 
as exfoliated tumor cells [7], normal uroepithelial cells and 
leukocytes. Depending on the circumstances, tumor cell 
DNA could be enriched in either one or both DNA fractions. 
Therefore, proper differentiation between cell-free DNA 
released from disintegrated cells and DNA of intact cells in 
urine could add an additional value for diagnostic purposes. 
Basic prerequisites for use in diagnostics are an appropriate 
amount of each DNA fraction and sufficient quality for suc-
cessful application in various PCR amplification procedures. 
In particular, altered DNA methylation is commonly found 
in urological malignancies [8,9] and should represent a use-
ful source of beneficial biomarkers. DNA, and especially  
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cell-free DNA isolated from urine should therefore be suit-
able for Methylation Specific PCR which includes bisulfite 
treatment, a routine technical step, which is inevitably asso-
ciated with some chemically-induced degradation of the ge-
netic material with diminished PCR efficiency as a conse-
quence.  
 Voided native urine is transferred into a 50 ml sample 
tube and is immediately put on ice for short-term storage (5-
10 min). Long-term storage should be done at -20°C or -
80°C. Even after up to 18 months of storage at -20°C we 
observed that DNA can be isolated from urine and can be 
amplified even after bisulfite treatment. We suggest thawing 
of urine samples by placing the sample tube for 60 min in 
water at room-temperature. After thawing all cells are sepa-
rated from one, still cold (0-4°C) 5 ml urine sample either by 
centrifugation at 4,000 rpm for 10 min or if cellular DNA 
will not be used anymore by a 0.22 ?m filter. From the su-
pernatant the cell-free DNA is either isolated by the 
NORGEN Urine DNA Isolation Kit (Biotek Corporation, 
Ontario, Canada) using one single column with 25 ?l elution 
buffer or, alternatively, by conventional precipitation with 1 
volume isopropanol from a 0.3 M sodium acetate solution 
(pH 5.2). DNA is sedimented by centrifugation at 15,000 
rpm for 20 min and washed twice by 70% ice cold ethanol. 
Cellular DNA was isolated from the urinary precipitate using 
the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) or 
NORGEN Urine DNA Isolation Kit according to the manu-
facturer´s protocol. The average amount of cell-free DNA 
and of cellular DNA, isolated by these procedures from 
healthy individuals and tumor patients was 200-550 ng and 
400-1300 ng, respectively. In a third approach, the QIAamp 
Circulating Nucleic Acid Kit was used together with the 
QIAvac 24 plus Vacuum Manifold according to the manu-
facturer´s (Qiagen) protocol. It yielded almost double the 
amount of both DNA fractions in high quality from the same 
volume of urine.  
 On the left of Fig. (1A), urinary cell-free DNA is shown 
which is fragmented and covers a size range from 100 up to 
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2000 nucleotides. Both DNA fractions were subjected to 
bisulfite treatment by the EpiTect Kit (Qiagen). The con-
verted DNA served as template for amplification of methy-
lated LINE-1 sequences in a normalized real time MSP ap-
proach (Fig. 1B). In particular in samples from healthy do-
nors the degree of methylation should be nearly the same in 
both DNA fractions and differences should reflect differ-
ences in PCR efficiency. Indeed as shown in Fig. (1B) we 
reproducibly measured in both DNA fractions a similar de-
gree of DNA methylation. Thus the presented methods allow 
the isolation of cell-free and cellular DNA from urine in suf-
ficient amounts and quality. Both fractions gave reproducible 
results in MSP (Fig. 1B) and conventional PCR (data not 
shown).  
 To test, how long the urine could be stored at room tem-
perature before freezing, the urine was incubated with and 
without proteinase K (Qiagen) for 0, 4, 8, and 16 h at room 
temperature and total DNA was isolated by NORGEN Urine 
DNA Isolation Kit as recommended by the manufacturer, 
with the variation that 2 ml urine were used per sample for 
one column and 25 ?l elution buffer. From these samples 
methylated LINE1 fragments were comparatively enriched 
by real time MSP. The time course in Fig. (2) shows that 
PCR efficiency is reduced at the 16 h time point and that 
proteinase K treatment maintains PCR efficiency, since at 
time point 8 and 16 the DNA methylation appears more pro-































Fig. (1). Isolation of both urinary DNA fractions and MSP. Two samples of cell-free DNA and one sample of cellular DNA from urine are 
shown in A. They have been visualized by ethidium bromide staining on an agarose gel. The diagram below (B) shows the real time MSP 
result generated from urinary cell-free DNA (red bars) and cellular DNA (blue bars) from 21 tumor patient samples and 7 healthy donors 
(control), with primers specific for methylated LINE-1 promoter sequences.  
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 Thus short term storage of urine, for up to 4-8 hours at 
room temperature does not impair MSP efficiency, suggest-
ing that DNA is not significantly degraded by DNAses 
within this time window (Fig. 2). For longer procedures at 
room temperature we suggest to use 0.15 AU of proteinase K 
per 2 ml urine to maintain PCR efficiency.  
CONCLUSION 
 In conclusion with these protocols the proper separation 
of cell-free DNA from cellular DNA from urine samples can 
be achieved yielding both DNA fractions in a MSP/PCR 
ready quality. We consider that especially the cell-free DNA 
fraction from urine will gain in importance in the field of 
epigenetic biomarkers. In addition, our results suggest that 
urine should not be handled at room temperature for longer 
than 4-8 h without proteinase K if DNA should be preserved. 
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Fig. (2). Real time MSP amplification of methylated LINE-1 promoter sequences from total DNA isolated from urine samples which had 
been incubated with and without proteinase K for 0, 4, 8, and 16 h at room temperature.  
